ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,228,581, issued on Feb. 18, was assigned to SPHINGOTEC GMBH (Hennigsdorf, Germany).
"Adrenomedullin assays and methods for determining mature andrendomedullin" was invented by Andreas Bergmann (Berlin).
According to the abstract* released by the U.S. Patent & Trademark Office: "An in vitro method for therapy follow-up in septic patients wherein the concentration of mature ADM 1-52 and/or mature ADM 1-52-Gly in a sample of bodily fluid of said septic patient is determined using an assay containing two binders that bind to two different regions within the region of mature adrenomedullin and/or adrenomedullin-Gly that is amino acid 21-52-amid SEQ ID No. 1 or amino acid 21-52-Gly SEQ ID ...